ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|

Trending News

Piriformis Syndrome in Fibromyalgia

Sensory Distress: The Other Side of Fibromyalgia

Patient Harm: The Facts and the Effects of Fibromyalgia Diagnostic Criteria

Small Fiber Neuropathy Fibromyalgia Studies Mount: But Does SFN Cause Pain in FM?

Cognitive Dysfunction of Fibromyalgia Does Not Impair Driving Ability

The Functional Capacity Evaluation (FCE) and Your Disability Insurance Benefits

Study Finds Serotonin Decreases Sensitivity to Pain

Connectivity Between Brain Regions May Predict Fibromyalgia Drug Treatment Response

VIDEO: Ken Questions: The Chronically Ill & Disabled Parking

Fibromyalgia-Friendly Turkey Day Recipe Tips and Swaps

 
Print Page
Email Article

IV Immunoglobulin May Offer Significant Relief for Neuropathic Pain

  [ 14 votes ]   [ Discuss This Article ]
www.ProHealth.com • November 14, 2012


Article:
Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study
- Source: Pain Medicine, Oct 2012

By Stefano Jann, MD, et al.

[Note: Immunoglobulin, derived from human blood plasma and produced by immune B-cells, is typically used to treat those with immune deficiencies or autoimmune diseases, with generally at most mild side effects. Neuropathy is pain associated with damaged tissue or nerves, or poor microcirculation, and occurs with many disorders.(1) Research by pain expert Roland Staud has suggested many ME/CFS and fibromyalgia patients may have ‘small fiber neuropathy.’]

Abstract:
Introduction: Neuropathic pain is frequently associated with many peripheral nervous system diseases and its successful treatment is an area of significant and critical unmet need.

Methods: Twenty adult outpatients of both sexes who had been suffering from painful polyneuropathy resistant to conventional therapies for at least 6 months and up to a maximum of 5 years and who reported severity of pain greater than 60 units on a visual analog scale (VAS) at baseline were included in this open-label pilot study.

Patients were randomly 1:1 allocated to receive adjuvant intravenous immunoglobulin (IVIg) (Flebogamma®, 2 g/kg) in addition to their regular therapy or to continue with the previous therapy (control group).  [Note: The regular/previous therapies that were not knocking the patients’ pain down enough included pregabalin, oxcarbazepine, duloxetine, and/or oxycodone.]

Results: The mean value of pain intensity (VAS) in the IVIG group:

• Dropped from 88 at baseline to 49 after the first week, and to 28 after 4 weeks, [bolding added]

• While values in the control group only slightly changed, from 85 to 78 after 1 week and to 75 after 4 weeks (P < 0.01).

Almost 100% of patients reported strong/medium pain (Short Form McGill Pain Questionnaire) in both groups at baseline:

• While after 4 to 8 weeks, pain was reduced to moderate/light in 90% of patients in the IVIg group, [bolding added]

• Whereas no improvement was reported in the control group (P < 0.01).

In patients' quality of life, scores of the IVIg group (Short Form 36, Clinical Global Impression of Change, and Patient Global Impression of Change questionnaires) in all the follow-up were significantly higher than those of the control group (P < 0.01).

Conclusion: This unblinded pilot study showed a beneficial effect of IVIg on neuropathic pain intensity and quality of life in patients resistant to conventional treatments.

Source: Pain Medicine, Oct 2012;13(10) pp 1334-1341. DOI:10.1111/j.1526-4637.2012.01478.x, by Jann S, Francia A, Fruguglietti ME, De Toni Franceschini L, Sterzi R. Department of Neurology, Niguarda Hospital, Milan; Neurological Clinic, University La Sapienza, Rome, Italy.  [E-mail: stefano.jann@ospedaleniguarda.it]

___

1. Among the disorders that involve neuropathy are diabetes, chemotherapy damage, multiple sclerosis, shingles, spinal stenosis, peripheral artery disease, back/leg/hip problems, facial nerve problems, alcohol abuse, and more. Other studies have suggested that IVIg has the potential to reduce the pain of specific chronic painful conditions such as complex regional pain syndrome, and Sjogren’s syndrome.




Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Immune Support Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Fibro Freedom™ Fibro Freedom™
Soothes, strengthens & revitalizes

Natural Remedies

Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
VIDEO: Healthy Eating and Fibromyalgia VIDEO: Healthy Eating and Fibromyalgia
Broad Spectrum Protection Against Brain Aging Broad Spectrum Protection Against Brain Aging
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing